AngiomiRs	0	9	B-Gene_or_gene_product
-	9	10	O
-	10	11	O
key	11	14	O
regulators	15	25	O
of	26	28	O
angiogenesis	29	41	O
.	41	42	O

The	44	47	O
formation	48	57	O
of	58	60	O
new	61	64	O
blood	65	70	B-Multi-tissue_structure
vessels	71	78	I-Multi-tissue_structure
through	79	86	O
the	87	90	O
process	91	98	O
of	99	101	O
angiogenesis	102	114	O
is	115	117	O
critical	118	126	O
in	127	129	O
vascular	130	138	B-Multi-tissue_structure
development	139	150	O
and	151	154	O
homeostasis	155	166	O
.	166	167	O

Aberrant	168	176	O
angiogenesis	177	189	O
leads	190	195	O
to	196	198	O
a	199	200	O
variety	201	208	O
of	209	211	O
diseases	212	220	O
,	220	221	O
such	222	226	O
as	227	229	O
ischemia	230	238	O
and	239	242	O
cancer	243	249	B-Pathological_formation
.	249	250	O

Recent	251	257	O
studies	258	265	O
have	266	270	O
revealed	271	279	O
important	280	289	O
roles	290	295	O
for	296	299	O
miRNAs	300	306	O
in	307	309	O
regulating	310	320	O
endothelial	321	332	B-Cell
cell	333	337	I-Cell
(	338	339	O
EC	339	341	B-Cell
)	341	342	O
function	343	351	O
,	351	352	O
especially	353	363	O
angiogenesis	364	376	O
.	376	377	O

Mice	378	382	B-Organism
with	383	387	O
EC	388	390	B-Cell
-	390	391	O
specific	391	399	O
deletion	400	408	O
of	409	411	O
Dicer	412	417	B-Gene_or_gene_product
,	417	418	O
a	419	420	O
key	421	424	O
enzyme	425	431	O
for	432	435	O
generating	436	446	O
miRNAs	447	453	O
,	453	454	O
display	455	462	O
defective	463	472	O
postnatal	473	482	O
angiogenesis	483	495	O
.	495	496	O

Specific	497	505	O
miRNAs	506	512	O
(	513	514	O
angiomiRs	514	523	B-Gene_or_gene_product
)	523	524	O
have	525	529	O
recently	530	538	O
been	539	543	O
shown	544	549	O
to	550	552	O
regulate	553	561	O
angiogenesis	562	574	O
in	575	577	O
vivo	578	582	O
.	582	583	O

miRNA	584	589	B-Gene_or_gene_product
-	589	590	I-Gene_or_gene_product
126	590	593	I-Gene_or_gene_product
,	593	594	O
an	595	597	O
EC	598	600	B-Cell
-	600	601	O
restricted	601	611	O
miRNA	612	617	O
,	617	618	O
regulates	619	628	O
vascular	629	637	B-Multi-tissue_structure
integrity	638	647	O
and	648	651	O
developmental	652	665	O
angiogenesis	666	678	O
.	678	679	O

miR	680	683	B-Gene_or_gene_product
-	683	684	I-Gene_or_gene_product
378	684	687	I-Gene_or_gene_product
,	687	688	O
miR	689	692	B-Gene_or_gene_product
-	692	693	I-Gene_or_gene_product
296	693	696	I-Gene_or_gene_product
,	696	697	O
and	698	701	O
the	702	705	O
miR	706	709	B-Gene_or_gene_product
-	709	710	I-Gene_or_gene_product
17	710	712	I-Gene_or_gene_product
-	712	713	I-Gene_or_gene_product
92	713	715	B-Gene_or_gene_product
cluster	716	723	O
contribute	724	734	O
to	735	737	O
tumor	738	743	B-Pathological_formation
angiogenesis	744	756	O
.	756	757	O

Manipulating	758	770	O
angiomiRs	771	780	B-Gene_or_gene_product
in	781	783	O
the	784	787	O
settings	788	796	O
of	797	799	O
pathological	800	812	O
vascularization	813	828	O
represents	829	839	O
a	840	841	O
new	842	845	O
therapeutic	846	857	O
approach	858	866	O
.	866	867	O

